|
|
Testosterone - Blood
Research News and Information
Definition of 'Testosterone'A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. Common names: Testosterone; 17-beta-Hydroxy-4-Androsten-3-one; 17 beta Hydroxy 4 Androsten 3 one; Androtop; Dr. Kade Brand of Testosterone; Histerone; Hauck Brand of Testosterone; Sterotate; Ulmer Brand of Testosterone; Sustanon; Androderm; Watson Brand of Testosterone; Faulding Brand of Testosterone |
Sunday, November 22, 2009
30 Oct 2009
BACKGROUND: Dutasteride is commonly used in patients that are also at risk for prostate cancer (PCa). Therefore, the influence of dutasteride on PCa markers has to be studied. To date, only the effect of dutasteride on serum prostate-specific ... Read more...
29 Sep 2009
The prostate, an androgen-regulated exocrine gland, is an integral part of the male reproductive system which has an essential function in sperm survival and motility in its long hostile route to meet and fertilise the egg in the Fallopian tube. ... Read more...
29 Sep 2009
While self-report screening instruments are highly sensitive to hypogonadism in the ageing male, they have lacked specificity as evidenced by low or absent correlations with testosterone. The purpose of this paper was to develop an economical and ... Read more...
Latest indexed articles for 'Testosterone - Blood'
These are the very latest articles for this heading:
- Preliminary evaluation of the effect of dutasteride on PCA3 in post-DRE urine sediments: a randomized, open-label, parallel-group pilot study.
30 Oct 2009 - Prostate cancer: a newly discovered route for testosterone to reach the prostate : Treatment by super-selective intraprostatic androgen deprivation.
29 Sep 2009 - Hypogonadism-related symptoms: development and evaluation of an empirically derived self-rating instrument (HRS 'Hypogonadism Related Symptom Scale').
29 Sep 2009 - Effects of primary testicular damage on sperm DNA oxidative status and embryonic and foetal development.
29 Sep 2009 - Predictors of improved seminal parameters and fertility after varicocele repair in young adults.
29 Sep 2009 - Editorial comment.
29 Sep 2009 - Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction.
13 Sep 2009 - Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study.
6 Sep 2009 - Effects of androgens on endothelial progenitor cells in vitro and in vivo.
5 Sep 2009 - Hormonal anticipation of territorial challenges in cichlid fish.
30 Aug 2009 - A case of Brugada syndrome in which diurnal ECG changes were associated with circadian rhythms of sex hormones.
30 Aug 2009 - [The androgen receptor and effects of testosterone]
30 Aug 2009 - [The key role of testosterone in male hypogonadism]
30 Aug 2009 - The effects of subchronic lithium administration in male Wistar mice on some biochemical parameters.
30 Aug 2009 - Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study.
30 Aug 2009 - Editorial comment.
30 Aug 2009 - Endogenous glutamate in association with inflammatory and hormonal factors modulates bone tissue resorption of the temporomandibular joint in patients with early rheumatoid arthritis.
30 Aug 2009 - Comparison of adolescents with Klinefelter syndrome according to the circumstances of diagnosis: amniocentesis versus clinical signs.
16 Aug 2009 - Serum hormones in patients with nonobstructive azoospermia after microdissection testicular sperm extraction.
13 Aug 2009 - Pediatric brain natriuretic peptide concentrations vary with age and sex and appear to be modulated by testosterone.
11 Aug 2009
See a longer list of these articles.
Technical information about 'Testosterone'
Definition: A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.
Chemical name: Androst-4-en-17beta-ol-3-one
Registry Number: 58-22-0
Descriptor UI: D013739
Alternative terms: Testosterone; 17-beta-Hydroxy-4-Androsten-3-one; 17 beta Hydroxy 4 Androsten 3 one; Androtop; Dr. Kade Brand of Testosterone; Histerone; Hauck Brand of Testosterone; Sterotate; Ulmer Brand of Testosterone; Sustanon; Androderm; Watson Brand of Testosterone; Faulding Brand of Testosterone; Paladin Brand of Testosterone; AstraZeneca Brand of Testosterone; CEPA Brand of Testosterone; Testoderm; Ortho Brand of Testosterone; Ferring Brand of Testosterone; Testolin; Pasadena Brand of Testosterone; Testopel; Bartor Brand of Testosterone; Testosterone Sulfate; AndroGel; Solvay Brand of Testosterone; Unimed Brand of Testosterone; Schering Brand of Testosterone; 8-Isotestosterone; 8 Isotestosterone; 17-beta-Hydroxy-8 alpha-4-Androsten-3-one; 17 beta Hydroxy 8 alpha 4 Androsten 3 one; Andropatch; SmithKline Beecham Brand of Testosterone; GlaxoSmithKline Brand of Testosterone; Testim; Auxilium Pharmaceuticals Inc. Brand of Testosterone;
Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Pharmacological Action: Androgens;
Tree Number: D04.808.054.079.429.824; D06.472.334.851.968.984;
History Note: 1963; for SUSTANON use TESTOSTERONE (NM) 1976-2003; /therapeutic use was TESTOSTERONE, THERAPEUTIC 1965
Technical Notes: TESTOSTERONE PROPIONATE is also available